These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28440407)

  • 1. Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia.
    Huang Z; Wang J; Qian J; Li Y; Xu Z; Chen M; Tong H
    Mol Med Rep; 2017 Jun; 15(6):3493-3498. PubMed ID: 28440407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of CYP3A5*3 on risk and prognosis in childhood acute lymphoblastic leukemia.
    Borst L; Wallerek S; Dalhoff K; Rasmussen KK; Wesenberg F; Wehner PS; Schmiegelow K
    Eur J Haematol; 2011 Jun; 86(6):477-83. PubMed ID: 21418106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of CYP3A5 mRNA in children with acute leukemia].
    Huang Z; Chai YH; Cen JN; He HL; Li J
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):549-54. PubMed ID: 19650988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relationship between cytochrome P450, subfamily IIIA, polypeptide 5 gene and drug resistance in leukemia cell lines].
    Wang T; Chen FY; Han JY; Zhong JH; Teng Y; Ouyang RR
    Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):527-9. PubMed ID: 15312409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of race on the CYP3A-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia.
    Sims RP
    J Oncol Pharm Pract; 2016 Feb; 22(1):76-81. PubMed ID: 25305360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CYP3A5 Expression and Vincristine Neurotoxicity in Pediatric Malignancies in Turkish Population.
    Kayilioğlu H; Kocak U; Kan Karaer D; Percin EF; Sal E; Tekkesin F; Isik M; Oner N; Belen FB; Yilmaz Keskin E; Okur A; Albayrak M; Kaya Z; Pinarli FG; Yenicesu I; Karadeniz C; Oguz A; Gursel T
    J Pediatr Hematol Oncol; 2017 Aug; 39(6):458-462. PubMed ID: 28697165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polymorphisms of CYP3A5 gene in acute leukemia patients and their role in chemotherapy and prognosis].
    Shen LJ; Chen FY; Wang T; Wang HR; Zhong JH; Han JY; Ouyang RR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):26-30. PubMed ID: 18315894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of the CYP3A5 gene and its effect on tacrolimus blood level.
    Nair SS; Sarasamma S; Gracious N; George J; Anish TS; Radhakrishnan R
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():197-200. PubMed ID: 25894154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies.
    Blanco JG; Edick MJ; Hancock ML; Winick NJ; Dervieux T; Amylon MD; Bash RO; Behm FG; Camitta BM; Pui CH; Raimondi SC; Relling MV
    Pharmacogenetics; 2002 Nov; 12(8):605-11. PubMed ID: 12439220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia.
    Hartman A; van Schaik RH; van der Heiden IP; Broekhuis MJ; Meier M; den Boer ML; Pieters R
    Leuk Res; 2010 Feb; 34(2):154-9. PubMed ID: 19467705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.
    Sági JC; Egyed B; Kelemen A; Kutszegi N; Hegyi M; Gézsi A; Herlitschke MA; Rzepiel A; Fodor LE; Ottóffy G; Kovács GT; Erdélyi DJ; Szalai C; Semsei ÁF
    BMC Cancer; 2018 Jul; 18(1):704. PubMed ID: 29970035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of CYP3A5*3 and CYP3A5*6 gene polymorphisms in Indian chronic myeloid leukemia patients.
    Sailaja K; Rao DN; Rao DR; Vishnupriya S
    Asian Pac J Cancer Prev; 2010; 11(3):781-4. PubMed ID: 21039054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy?
    Bedewy AM; El-Maghraby SM
    Hematology; 2013 Jul; 18(4):211-6. PubMed ID: 23394475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population.
    Krishnakumar D; Gurusamy U; Dhandapani K; Surendiran A; Baghel R; Kukreti R; Gangadhar R; Prayaga U; Manjunath S; Adithan C
    Fundam Clin Pharmacol; 2012 Apr; 26(2):295-306. PubMed ID: 21265876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor Genotype and Intragraft Expression of CYP3A5 Reflect the Response to Steroid Treatment During Acute Renal Allograft Rejection.
    Rekers NV; Flaig TM; Mallat MJK; Spruyt-Gerritse MJ; Zandbergen M; Anholts JDH; Bajema IM; Clahsen-van Groningen MC; Yang J; de Fijter JW; Claas FHJ; Brakemeier S; Lachmann N; Kreutz R; de Heer E; Budde K; Bolbrinker J; Eikmans M
    Transplantation; 2017 Sep; 101(9):2017-2025. PubMed ID: 27926596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cytochrome P450 3A5 polymorphism in graft livers on the frequency of acute cellular rejection in living-donor liver transplantation.
    Uesugi M; Kikuchi M; Shinke H; Omura T; Yonezawa A; Matsubara K; Fujimoto Y; Okamoto S; Kaido T; Uemoto S; Masuda S
    Pharmacogenet Genomics; 2014 Jul; 24(7):356-66. PubMed ID: 24911663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rs776746 variant of CYP3A5 is associated with intravenous midazolam plasma levels and higher clearance in critically ill Mexican paediatric patients.
    Flores-Pérez C; Castillejos-López MJ; Chávez-Pacheco JL; Dávila-Borja VM; Flores-Pérez J; Zárate-Castañón P; Acosta-Bastidas M; Cruz-Escobar J; Torres-Espíndola LM
    J Clin Pharm Ther; 2021 Jun; 46(3):633-639. PubMed ID: 33638195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
    Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients.
    Miura M; Satoh S; Inoue K; Kagaya H; Saito M; Inoue T; Habuchi T; Suzuki T
    Steroids; 2008 Oct; 73(11):1052-9. PubMed ID: 18502461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia.
    Aplenc R; Glatfelter W; Han P; Rappaport E; La M; Cnaan A; Blackwood MA; Lange B; Rebbeck T
    Br J Haematol; 2003 Jul; 122(2):240-4. PubMed ID: 12846892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.